<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36575535</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>56</StartPage><MedlinePgn>56</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">56</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00331-z</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a disease characterized by upper and lower motor neuron (MN) loss with a signature feature of cytoplasmic aggregates containing TDP-43, which are detected in nearly all patients. Mutations in the gene that encodes TDP-43 (TARBDP) are known to result in both familial and sporadic ALS. In ALS, disruption of neuromuscular junctions (NMJs) constitutes a critical event in disease pathogenesis, leading to denervation atrophy, motor impairments and disability. Morphological defects and impaired synaptic transmission at NMJs have been reported in several TDP-43 animal models and in vitro, linking TDP-43 dysregulation to the loss of NMJ integrity in ALS. Through the lens of the dying-back and dying-forward hypotheses of ALS, this review discusses the roles of TDP-43 related to synaptic function, with a focus on the potential molecular mechanisms occurring within MNs, skeletal muscles and glial cells that may contribute to NMJ disruption in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>L&#xe9;pine</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, 3801 University Street, Montreal, QC, H3A 2B4, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Health Sciences, McGill University, 3605 De La Montagne, Montreal, QC, H3G 2M1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castellanos-Montiel</LastName><ForeName>Maria Jos&#xe9;</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>The Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, 3801 University Street, Montreal, QC, H3A 2B4, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durcan</LastName><ForeName>Thomas Martin</ForeName><Initials>TM</Initials><Identifier Source="ORCID">0000-0003-3942-1956</Identifier><AffiliationInfo><Affiliation>The Neuro's Early Drug Discovery Unit (EDDU), Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, 3801 University Street, Montreal, QC, H3A 2B4, Canada. thomas.durcan@mcgill.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PJT - 169095</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Denervation</Keyword><Keyword MajorTopicYN="N">Dying-back</Keyword><Keyword MajorTopicYN="N">Dying-forward</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36575535</ArticleId><ArticleId IdType="pmc">PMC9793560</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00331-z</ArticleId><ArticleId IdType="pii">10.1186/s40035-022-00331-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Charcot J-M, Joffroy A. Deux cas d&#x2019;atrophie musculaire progressive avec l&#xe9;sions de la substance grise et des faiseaux ant&#xe9;ro-lat&#xe9;raux de la moelle &#xe9;pini&#xe8;re. Arch Physiol Norm Pathol. 1869;2:744&#x2013;760.</Citation></Reference><Reference><Citation>Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248:612&#x2013;6. doi: 10.1007/s004150170140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150170140</ArticleId><ArticleId IdType="pubmed">11518004</ArticleId></ArticleIdList></Reference><Reference><Citation>del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology. 2003;60:813&#x2013;9. doi: 10.1212/01.WNL.0000049472.47709.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585&#x2013;91. doi: 10.1056/NEJM199403033300901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Meininger V, Leigh P, Guillet P. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet. 1996;347:1425&#x2013;31. doi: 10.1016/S0140-6736(96)91680-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchcliffe M, Smith A. Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degener Neurol Neuromuscul Dis. 2017;7:61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053101</ArticleId><ArticleId IdType="pubmed">30050378</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Aoki M, Tsuji S, Itoyama Y, Sobue G, Togo M, et al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:505&#x2013;12. doi: 10.1016/S1474-4422(17)30115-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakata T, Palumbo J, Akimoto M, Tanaka M. A long-term safety and efficacy extension study of patients diagnosed with amyotrophic lateral sclerosis (ALS) and treated with edaravone (MCI-186) Neurology. 2016;86:Suppl. P3.192.</Citation></Reference><Reference><Citation>Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, et al. Trial of sodium phenylbutyrate&#x2013;taurursodiol for amyotrophic lateral sclerosis. N Engl J Med. 2020;383:919&#x2013;30. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pmc">PMC9134321</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Knowlton N, Hendrix K, Ellison N, Dickson S, Hendrix S, et al. Long-term treatment with AMX0035 in the open-label extension of CENTAUR, a randomized controlled trial in individuals with amyotrophic lateral sclerosis. Muscle Nerve. 2020;62:105.</Citation></Reference><Reference><Citation>Paganoni S, Hendrix S, Dickson SP, Knowlton N, Macklin EA, Berry JD, et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021;63:31&#x2013;9. doi: 10.1002/mus.27091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27091</ArticleId><ArticleId IdType="pmc">PMC7820979</ArticleId><ArticleId IdType="pubmed">33063909</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi ABRH. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377:162&#x2013;72. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sayana P, Zhang X, Le W. Genetics of amyotrophic lateral sclerosis: an update. Mol Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, et al. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol. 2008;63:535&#x2013;8. doi: 10.1002/ana.21344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21344</ArticleId><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Velde C, Vande, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet. 2008;40:572&#x2013;4. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;72. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;16. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Cleveland DW, Rethinking ALS. The FUS about TDP-43. Cell. 2009;136:1001&#x2013;4. doi: 10.1016/j.cell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;11. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;3. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427&#x2013;34. doi: 10.1002/ana.21147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21147</ArticleId><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Felice KJ. A longitudinal study comparing thenar motor unit number estimates to other quantitative tests in patients with amyotrophic lateral sclerosis. Muscle Nerve. 1997;20:179&#x2013;85. doi: 10.1002/(SICI)1097-4598(199702)20:2&lt;179::AID-MUS7&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199702)20:2&lt;179::AID-MUS7&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">9040656</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;40. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Killian JM, Wilfong AA, Burnett L, Appel SH, Boland D. Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve. 1994;17:747&#x2013;54. doi: 10.1002/mus.880170708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880170708</ArticleId><ArticleId IdType="pubmed">8008001</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci. 2000;20:2534&#x2013;42. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli RA, Wollman RL, Leung C, Distad B, Palombi S, Richman DP, et al. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1193&#x2013;203. doi: 10.1002/mus.880161109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880161109</ArticleId><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain. 2006;129:2436&#x2013;46. doi: 10.1093/brain/awl172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl172</ArticleId><ArticleId IdType="pubmed">16835248</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain. 2008;131:1540&#x2013;50. doi: 10.1093/brain/awn071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Nicholson GA, Ng K, Howells J, Kril JJ, et al. Cortical function in asymptomatic carriers and patients with C9orf72 amyotrophic lateral sclerosis. JAMA Neurol. 2015;72:1268. doi: 10.1001/jamaneurol.2015.1872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1872</ArticleId><ArticleId IdType="pmc">PMC4707047</ArticleId><ArticleId IdType="pubmed">26348842</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S. Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol. 2015;126:803&#x2013;9. doi: 10.1016/j.clinph.2014.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId><ArticleId IdType="pubmed">25227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Blizzard CA, Southam KA, Dawkins E, Lewis KE, King AE, Clark JA, et al. Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis: vulnerability of lower motor neurons to proximal excitotoxicity. Dis Model Mech. 2015;8:215&#x2013;24. doi: 10.1242/dmm.018606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.018606</ArticleId><ArticleId IdType="pmc">PMC4348560</ArticleId><ArticleId IdType="pubmed">25740331</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470&#x2013;7. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci. 2014;8:1&#x2013;18. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, Kiernan MC, Vucic S. Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol. 2016;12:651&#x2013;61. doi: 10.1038/nrneurol.2016.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Braak H, Del Tredici K, Lemon R, Ludolph AC, Kiernan MC. Cortical influences drive amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:917&#x2013;24. doi: 10.1136/jnnp-2017-315573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315573</ArticleId><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, Fellner L, Haybaeck J, Wenning GK. Development of neurodegeneration in amyotrophic lateral sclerosis: from up or down? J Neural Transm. 2020;127:1097&#x2013;105. doi: 10.1007/s00702-020-02213-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-020-02213-y</ArticleId><ArticleId IdType="pubmed">32500222</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F, Godena VK, Romano G, D&#x2019;Ambrogio A, Klima R, Baralle FE. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583:1586&#x2013;92. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ray P, Rao EJ, Shi C, Guo W, Chen X, et al. A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A. 2010;107:3169&#x2013;74. doi: 10.1073/pnas.0913602107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0913602107</ArticleId><ArticleId IdType="pmc">PMC2840283</ArticleId><ArticleId IdType="pubmed">20133767</ArticleId></ArticleIdList></Reference><Reference><Citation>Godena VK, Romano G, Romano M, Appocher C, Klima R, Buratti E, et al. TDP-43 regulates Drosophila neuromuscular junctions growth by modulating futsch/MAP1B levels and synaptic microtubules organization. PLoS ONE. 2011;6:e17808. doi: 10.1371/journal.pone.0017808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017808</ArticleId><ArticleId IdType="pmc">PMC3055892</ArticleId><ArticleId IdType="pubmed">21412434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J-W, Brent JR, Tomlinson A, Shneider NA, McCabe BD. The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest. 2011;121:4118&#x2013;26. doi: 10.1172/JCI57883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI57883</ArticleId><ArticleId IdType="pmc">PMC3195475</ArticleId><ArticleId IdType="pubmed">21881207</ArticleId></ArticleIdList></Reference><Reference><Citation>Donde A, Sun M, Ling JP, Braunstein KE, Pang B, Wen X, et al. Splicing repression is a major function of TDP-43 in motor neurons. Acta Neuropathol. 2019;138:813&#x2013;26. doi: 10.1007/s00401-019-02042-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02042-8</ArticleId><ArticleId IdType="pmc">PMC6802294</ArticleId><ArticleId IdType="pubmed">31332509</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Boehringer A, Zwick R, Tang JE, Grigsby B, Zarnescu DC. Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet. 2011;20:2308&#x2013;21. doi: 10.1093/hmg/ddr124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr124</ArticleId><ArticleId IdType="pmc">PMC3098735</ArticleId><ArticleId IdType="pubmed">21441568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M-J, Cheng C-W, Shen C-KJ. Neuronal function and dysfunction of Drosophila dTDP. PLoS ONE. 2011;6:e20371. doi: 10.1371/journal.pone.0020371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020371</ArticleId><ArticleId IdType="pmc">PMC3105987</ArticleId><ArticleId IdType="pubmed">21673800</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper DC, Adachi Y, Sutcliffe B, Humphrey DM, Elliott CJH, Stepto A, et al. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet. 2013;22:1539&#x2013;57. doi: 10.1093/hmg/ddt005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt005</ArticleId><ArticleId IdType="pmc">PMC3605831</ArticleId><ArticleId IdType="pubmed">23307927</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes PS, Daniel SG, Mccallum AP, Boehringer AV, Sukhina AS, Zwick RA, et al. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis. DMM Dis Model Mech. 2013;6:721&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3634655</ArticleId><ArticleId IdType="pubmed">23471911</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano G, Klima R, Buratti E, Verstreken P, Baralle FE, Feiguin F. Chronological requirements of TDP-43 function in synaptic organization and locomotive control. Neurobiol Dis. 2014;71:95&#x2013;109. doi: 10.1016/j.nbd.2014.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.07.007</ArticleId><ArticleId IdType="pubmed">25088713</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshpande M, Feiger Z, Shilton AK, Luo CC, Silverman E, Rodal AA. Role of BMP receptor traffic in synaptic growth defects in an ALS model. Mol Biol Cell. 2016;27:2898&#x2013;910. doi: 10.1091/mbc.E16-07-0519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-07-0519</ArticleId><ArticleId IdType="pmc">PMC5042577</ArticleId><ArticleId IdType="pubmed">27535427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, Bourgouin P, et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet. 2010;19:671&#x2013;83. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E, Bercier V, Lissouba A, Liao M, Brustein E, Rouleau GA, et al. FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet. 2011;7:e1002214. doi: 10.1371/journal.pgen.1002214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002214</ArticleId><ArticleId IdType="pmc">PMC3150442</ArticleId><ArticleId IdType="pubmed">21829392</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzieciolowska S, Drapeau P, Armstrong GAB. Augmented quantal release of acetylcholine at the vertebrate neuromuscular junction following tdp-43 depletion. PLoS ONE. 2017;12:e0177005. doi: 10.1371/journal.pone.0177005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177005</ArticleId><ArticleId IdType="pmc">PMC5417676</ArticleId><ArticleId IdType="pubmed">28472174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose P, Armstrong GAB, Drapeau P. Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43. J Neurophysiol. 2019;121:285&#x2013;97. doi: 10.1152/jn.00265.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00265.2018</ArticleId><ArticleId IdType="pubmed">30461368</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M-L, Marian A, Ciura S, Kabashi E. TDP-43 regulation of AChE expression can mediate ALS-like phenotype in zebrafish. Cells. 2021;10:221. doi: 10.3390/cells10020221.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020221</ArticleId><ArticleId IdType="pmc">PMC7911940</ArticleId><ArticleId IdType="pubmed">33499374</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GAB, Drapeau P. Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J Neurosci. 2013;33:1741&#x2013;52. doi: 10.1523/JNEUROSCI.4003-12.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pmc">PMC6618732</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten SA, Aggad D, Martinez J, Tremblay E, Petrillo J, Armstrong GAB, et al. Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI Insight. 2017;2:e97152. doi: 10.1172/jci.insight.97152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.97152</ArticleId><ArticleId IdType="pmc">PMC5752378</ArticleId><ArticleId IdType="pubmed">29202456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A. 2009;106:18809&#x2013;14. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang C, Chen H, Wang D, Landel CP, Xia PY, et al. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet. 2010;6:e1000887. doi: 10.1371/journal.pgen.1000887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000887</ArticleId><ArticleId IdType="pmc">PMC2845661</ArticleId><ArticleId IdType="pubmed">20361056</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S-L, Wu L-S, Lee M, Chang C-W, Cheng W-C, Fang Y-S, et al. A robust TDP-43 knock-in mouse model of ALS. Acta Neuropathol Commun. 2020;8:3. doi: 10.1186/s40478-020-0881-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-0881-5</ArticleId><ArticleId IdType="pmc">PMC6975031</ArticleId><ArticleId IdType="pubmed">31964415</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh JN, Tosolini AP, Gordon D, Devoy A, Fratta P, Fisher EMC, et al. Mice carrying ALS mutant TDP-43, but not mutant FUS, display in vivo defects in axonal transport of signaling endosomes. Cell Rep. 2020;30:3655&#x2013;62.e2. doi: 10.1016/j.celrep.2020.02.078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.02.078</ArticleId><ArticleId IdType="pmc">PMC7090381</ArticleId><ArticleId IdType="pubmed">32187538</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, et al. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain. 2011;134:2610&#x2013;26. doi: 10.1093/brain/awr159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr159</ArticleId><ArticleId IdType="pubmed">21752789</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling S-C, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A. 2013;110:e736-45. doi: 10.1073/pnas.1222809110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, Constable R, So E, Vance C, Scotter E, Glover L, et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol Commun. 2015;3:36. doi: 10.1186/s40478-015-0212-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0212-4</ArticleId><ArticleId IdType="pmc">PMC4479086</ArticleId><ArticleId IdType="pubmed">26108367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Lee JD, Qiu H, Willis EF, Lavidis NA, et al. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43 Q331K transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2018;32:2676&#x2013;89. doi: 10.1096/fj.201700835R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700835R</ArticleId><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein SY, Yagudayeva I, Shneider NA. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 2019;26:364&#x2013;73.e4. doi: 10.1016/j.celrep.2018.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.045</ArticleId><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D, Dafinca R, Scaber J, Alegre-Abarrategui J, Farrimond L, Scott C, et al. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiol Dis. 2019;121:148&#x2013;62. doi: 10.1016/j.nbd.2018.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.09.024</ArticleId><ArticleId IdType="pubmed">30290270</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson MG, Finelli MJ, Sleigh JN, Reddington A, Gordon D, Talbot K, et al. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo. Hum Mol Genet. 2019;28:3584&#x2013;99. doi: 10.1093/hmg/ddz190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz190</ArticleId><ArticleId IdType="pmc">PMC6927465</ArticleId><ArticleId IdType="pubmed">31642482</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Lin Z, Kim E, Henstridge CM, Pena Altamira E, Hunt CK, et al. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss. Acta Neuropathol Commun. 2019;7:166. doi: 10.1186/s40478-019-0800-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0800-9</ArticleId><ArticleId IdType="pmc">PMC6819591</ArticleId><ArticleId IdType="pubmed">31661035</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Uzel SGM, Kamm RD. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv. 2018;4:1&#x2013;16. doi: 10.1126/sciadv.aat5847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aat5847</ArticleId><ArticleId IdType="pmc">PMC6179377</ArticleId><ArticleId IdType="pubmed">30324134</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JD, DuBreuil DM, Devlin A-C, Held A, Sapir Y, Berezovski E, et al. Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat Commun. 2021;12:4744. doi: 10.1038/s41467-021-24776-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24776-4</ArticleId><ArticleId IdType="pmc">PMC8346474</ArticleId><ArticleId IdType="pubmed">34362895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SH, Wu F, Harrich D, Garc&#xed;a-Mart&#xed;nez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol. 1995;69:3584&#x2013;96. doi: 10.1128/jvi.69.6.3584-3596.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.69.6.3584-3596.1995</ArticleId><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001;20:1774&#x2013;84. doi: 10.1093/emboj/20.7.1774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/20.7.1774</ArticleId><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra J, Guerrero EN, Hegde PM, Liachko NF, Wang H, Vasquez V, et al. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proc Natl Acad Sci U S A. 2019;116:4696&#x2013;705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A, Whelan DR, Jamali MS, Perri E, Shahheydari H, Toth RP, et al. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations. Mol Neurodegener. 2020;15:51. doi: 10.1186/s13024-020-00386-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00386-4</ArticleId><ArticleId IdType="pmc">PMC7488163</ArticleId><ArticleId IdType="pubmed">32907630</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J-F, Majumder P, Chatterjee B, Huang S-L, Shen C-KJ. TDP-43 regulates coupled dendritic mRNA transport-translation processes in co-operation with FMRP and Staufen1. Cell Rep. 2019;29:3118&#x2013;33.e6. doi: 10.1016/j.celrep.2019.10.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.061</ArticleId><ArticleId IdType="pubmed">31801077</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81:536&#x2013;43. doi: 10.1016/j.neuron.2013.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pmc">PMC3939050</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Bassell GJ, Rossoll W. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet. 2012;21:3703&#x2013;18. doi: 10.1093/hmg/dds205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds205</ArticleId><ArticleId IdType="pmc">PMC3406762</ArticleId><ArticleId IdType="pubmed">22641816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaur ELF. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114:e2466-75. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res. 2010;9:1104&#x2013;20. doi: 10.1021/pr901076y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr901076y</ArticleId><ArticleId IdType="pmc">PMC2897173</ArticleId><ArticleId IdType="pubmed">20020773</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I-F, Wu L-S, Chang H-Y, Shen C-KJ. TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem. 2008;105:797&#x2013;806. doi: 10.1111/j.1471-4159.2007.05190.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05190.x</ArticleId><ArticleId IdType="pubmed">18088371</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J. 2010;277:2268&#x2013;81. doi: 10.1111/j.1742-4658.2010.07643.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07643.x</ArticleId><ArticleId IdType="pubmed">20423455</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A. 2012;109:3347&#x2013;52. doi: 10.1073/pnas.1112427109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1112427109</ArticleId><ArticleId IdType="pmc">PMC3295278</ArticleId><ArticleId IdType="pubmed">22323604</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111:1051&#x2013;61. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L, Bilgutay A, Zhang Y-J, Vanderwyde T, Citro A, Mehta T, et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P, Good SK, et al. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol. 2011;31:1098&#x2013;108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald KK, Aulas A, Destroismaisons L, Pickles S, Beleac E, Camu W, et al. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum Mol Genet. 2011;20:1400&#x2013;10. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakawa K, Handa H, Kawakami K. Optogenetic modulation of TDP-43 oligomerization accelerates ALS-related pathologies in the spinal motor neurons. Nat Commun. 2020;11:1004. doi: 10.1038/s41467-020-14815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14815-x</ArticleId><ArticleId IdType="pmc">PMC7035286</ArticleId><ArticleId IdType="pubmed">32081878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsuzawa S, Suzuki N, Akiyama T, Ishikawa M, Sone T, Kawada J, et al. Reduced PHOX2B stability causes axonal growth impairment in motor neurons with TARDBP mutations. Stem Cell Reports. 2021;16:1527&#x2013;41. doi: 10.1016/j.stemcr.2021.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.04.021</ArticleId><ArticleId IdType="pmc">PMC8190591</ArticleId><ArticleId IdType="pubmed">34048688</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, Kim E, Duffy A, Adalbert R, Phillips BU, Peters OM, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat Neurosci. 2018;21:552&#x2013;63. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H, et al. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J. 2018;37:1&#x2013;15. doi: 10.15252/embj.201798684.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pmc">PMC5983119</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S, Oiwa K, Murata Y, Komine O, Sobue A, Endo F, et al. ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration. Mol Brain. 2020;13:8. doi: 10.1186/s13041-020-0550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0550-4</ArticleId><ArticleId IdType="pmc">PMC6971932</ArticleId><ArticleId IdType="pubmed">31959210</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011;14:459&#x2013;68. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;5. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, Yalamanchili HK, Park J, De Maio A, Lu HC, Wan YW, et al. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum Mol Genet. 2016;25:5083&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey J, Emmett W, Fratta P, Isaacs AM, Plagnol V. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med Genom. 2017;10:38. doi: 10.1186/s12920-017-0274-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0274-1</ArticleId><ArticleId IdType="pmc">PMC5446763</ArticleId><ArticleId IdType="pubmed">28549443</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown A, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603:131&#x2013;7. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem. 2011;286:1204&#x2013;15. doi: 10.1074/jbc.M110.190884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.190884</ArticleId><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452&#x2013;8. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao S, Sanelli T, Dib S, Sheps D, Findlater J, Bilbao J, et al. RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS. Mol Cell Neurosci. 2011;47:167&#x2013;80. doi: 10.1016/j.mcn.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2011.02.013</ArticleId><ArticleId IdType="pubmed">21421050</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra M, Paunesku T, Woloschak GE, Siddique T, Zhu L, Lin S, et al. Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol. 2007;114:81&#x2013;94. doi: 10.1007/s00401-007-0240-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0240-7</ArticleId><ArticleId IdType="pubmed">17569064</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD&#x2013;ALS gene UNC13A. Nature. 2022;603:124&#x2013;30. doi: 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda D, Ishigaki S, Iguchi Y, Fujioka Y, Udagawa T, Masuda A, et al. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio. 2014;4:1&#x2013;10. doi: 10.1016/j.fob.2013.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fob.2013.11.001</ArticleId><ArticleId IdType="pmc">PMC3851184</ArticleId><ArticleId IdType="pubmed">24319651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Noakes PG, Moscoso L, Rupp F, Scheller RH, Merlie JP, et al. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell. 1996;85:525&#x2013;35. doi: 10.1016/S0092-8674(00)81253-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81253-2</ArticleId><ArticleId IdType="pubmed">8653788</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins MA, An J, Hood BL, Conrads TP, Bowser RP. Label-free LC&#x2013;MS/MS proteomic analysis of cerebrospinal fluid identifies protein/pathway alterations and candidate biomarkers for amyotrophic lateral sclerosis. J Proteome Res. 2015;14:4486&#x2013;501. doi: 10.1021/acs.jproteome.5b00804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.5b00804</ArticleId><ArticleId IdType="pmc">PMC5592736</ArticleId><ArticleId IdType="pubmed">26401960</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Siddegowda BB, Estes PS, Johannesmeyer J, Kovalik T, Daniel SG, et al. FUTSCH/MAP1B mRNA is a translational target of TDP-43 and is neuroprotective in a Drosophila model of amyotrophic lateral sclerosis. J Neurosci. 2014;34:15962&#x2013;74. doi: 10.1523/JNEUROSCI.2526-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2526-14.2014</ArticleId><ArticleId IdType="pmc">PMC4244467</ArticleId><ArticleId IdType="pubmed">25429138</ArticleId></ArticleIdList></Reference><Reference><Citation>Strah N, Romano G, Introna C, Klima R, Marzullo M, Ciapponi L, et al. TDP-43 promotes the formation of neuromuscular synapses through the regulation of disc-large expression in Drosophila skeletal muscles. BMC Biol. 2020;18:34. doi: 10.1186/s12915-020-00767-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-020-00767-7</ArticleId><ArticleId IdType="pmc">PMC7099817</ArticleId><ArticleId IdType="pubmed">32216790</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos J, Hummel T, Ng N, Kl&#xe4;mbt C, Davis GW. Drosophila Futsch regulates synaptic microtubule organization and is necessary for synaptic growth. Neuron. 2000;26:371&#x2013;82. doi: 10.1016/S0896-6273(00)81170-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)81170-8</ArticleId><ArticleId IdType="pubmed">10839356</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudel J, Heckmann M. Desensitization reduces amplitudes of quantal end-plate currents after a single preceding end-plate current in mouse muscle. Pflug Arch Eur J Physiol. 1999;437:569&#x2013;76. doi: 10.1007/s004240050819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004240050819</ArticleId><ArticleId IdType="pubmed">10089570</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler M, Manley HA, Purcell AL, Deshpande SS, Hamilton TA, Kan RK, et al. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve. 2004;30:317&#x2013;27. doi: 10.1002/mus.20099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20099</ArticleId><ArticleId IdType="pubmed">15318343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W, Dominguez B, Yang J, Aryal P, Brandon EP, Gage FH, et al. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron. 2005;46:569&#x2013;79. doi: 10.1016/j.neuron.2005.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.04.002</ArticleId><ArticleId IdType="pubmed">15944126</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard E, Bernard V, Camp S, Taylor P, Krejci E, Molg&#xf3; J. Remodeling of the neuromuscular junction in mice with deleted exons 5 and 6 of acetylcholinesterase. J Mol Neurosci. 2006;30:99&#x2013;100. doi: 10.1385/JMN:30:1:99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:30:1:99</ArticleId><ArticleId IdType="pubmed">17192646</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S, &#xc4;ij&#xf6; T, Vickovic S, Braine C, Kang K, Mollbrink A, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi T, Rollins MG, Moinpour M, Morera AA, Ebmeier CC, Old WM, et al. Changes to the TDP-43 and FUS interactomes induced by DNA damage. J Proteome Res. 2020;19:360&#x2013;70. doi: 10.1021/acs.jproteome.9b00575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.9b00575</ArticleId><ArticleId IdType="pmc">PMC6947635</ArticleId><ArticleId IdType="pubmed">31693373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci U S A. 2016;113:e7701-9. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini M, Bayona-Feliu A, Sproviero D, Barroso SI, Cereda C, Aguilera A. TDP-43 mutations link amyotrophic lateral sclerosis with R-loop homeostasis and R loop-mediated DNA damage. PLOS Genet. 2020;16:e1009260. doi: 10.1371/journal.pgen.1009260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009260</ArticleId><ArticleId IdType="pmc">PMC7755276</ArticleId><ArticleId IdType="pubmed">33301444</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero EN, Mitra J, Wang H, Rangaswamy S, Hegde PM, Basu P, et al. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28:2459&#x2013;76. doi: 10.1093/hmg/ddz062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz062</ArticleId><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Jin L, Wang I, Wei W, Ho P, Liu Y, et al. HDAC1 dysregulation induces aberrant cell cycle and DNA damage in progress of TDP-43 proteinopathies. EMBO Mol Med. 2020;12:e10622. doi: 10.15252/emmm.201910622.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201910622</ArticleId><ArticleId IdType="pmc">PMC7278561</ArticleId><ArticleId IdType="pubmed">32449313</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein D, Toiber D. DNA damage and neurodegeneration: the unusual suspect. Neural Regen Res. 2017;12:1441&#x2013;2. doi: 10.4103/1673-5374.215254.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.215254</ArticleId><ArticleId IdType="pmc">PMC5649463</ArticleId><ArticleId IdType="pubmed">29089988</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, et al. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol. 2015;130:643&#x2013;60. doi: 10.1007/s00401-015-1460-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pmc">PMC5127391</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Cheung CJ, Restrepo CR, Kwong LK, Stieber AM, Trojanowski JQ, et al. Selective motor neuron resistance and recovery in a new inducible mouse model of TDP-43 proteinopathy. J Neurosci. 2016;36:7707&#x2013;17. doi: 10.1523/JNEUROSCI.1457-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1457-16.2016</ArticleId><ArticleId IdType="pmc">PMC6705561</ArticleId><ArticleId IdType="pubmed">27445147</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, Lojewski X, Japtok J, Vehlow A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552:335&#x2013;44. doi: 10.1113/jphysiol.2003.049478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2003.049478</ArticleId><ArticleId IdType="pmc">PMC2343396</ArticleId><ArticleId IdType="pubmed">14561818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Ultrastructural change of synapses of Betz cells in patients with amyotrophic lateral sclerosis. Neurosci Lett. 1999;268:29&#x2013;32. doi: 10.1016/S0304-3940(99)00374-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0304-3940(99)00374-2</ArticleId><ArticleId IdType="pubmed">10400070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem. 1997;69:2064&#x2013;74. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Pan L-H, Watanabe M, Kato T, Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci Lett. 1995;199:152&#x2013;4. doi: 10.1016/0304-3940(95)12039-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(95)12039-7</ArticleId><ArticleId IdType="pubmed">8584246</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Li X, Shi J, Guo Y, Li Z, Li C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience. 2010;169:1621&#x2013;9. doi: 10.1016/j.neuroscience.2010.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.06.018</ArticleId><ArticleId IdType="pubmed">20600671</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong K, Li Y, Duan W, Guo Y, Jiang H, Li W, et al. Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line. Neurosci Lett. 2012;530:144&#x2013;9. doi: 10.1016/j.neulet.2012.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.10.003</ArticleId><ArticleId IdType="pubmed">23063673</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, Colombrita C, Gumina V, Borghi MO, Dusi S, Doretti A, et al. Gene-specific mitochondria dysfunctions in human TARDBP and C9ORF72 fibroblasts. Acta Neuropathol Commun. 2016;4:47. doi: 10.1186/s40478-016-0316-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0316-5</ArticleId><ArticleId IdType="pmc">PMC4858818</ArticleId><ArticleId IdType="pubmed">27151080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G, Selleri V, Nasi M, De Gaetano A, Martinelli I, Gianferrari G, et al. Mitochondrial and endoplasmic reticulum alterations in a case of amyotrophic lateral sclerosis caused by TDP-43 A382T mutation. Int J Mol Sci. 2022;23:11881. doi: 10.3390/ijms231911881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231911881</ArticleId><ArticleId IdType="pmc">PMC9570187</ArticleId><ArticleId IdType="pubmed">36233180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Duan W, Guo Y, Jiang H, Li Z, Huang J, et al. Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin. Brain Res Bull. 2012;89:185&#x2013;90. doi: 10.1016/j.brainresbull.2012.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2012.09.005</ArticleId><ArticleId IdType="pubmed">22986236</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R, Barbagallo P, Farrimond L, Candalija A, Scaber J, Ababneh NA, et al. Impairment of mitochondrial calcium buffering links mutations in C9ORF72 and TARDBP in iPS-derived motor neurons from patients with ALS/FTD. Stem Cell Reports. 2020;14:892&#x2013;908. doi: 10.1016/j.stemcr.2020.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.03.023</ArticleId><ArticleId IdType="pmc">PMC7220989</ArticleId><ArticleId IdType="pubmed">32330447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Zhang H-X, Nishihira Y, Tan C-F, Takahashi H, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol. 2008;116:193&#x2013;203. doi: 10.1007/s00401-008-0396-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0396-9</ArticleId><ArticleId IdType="pubmed">18560845</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Li L, Lin W-L, Dickson DW, Petrucelli L, Zhang T, et al. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet. 2013;22:4706&#x2013;19. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22:869&#x2013;78. doi: 10.1038/nm.4130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4130</ArticleId><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X, Chiang P-M, Price DL, Wong PC. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci U S A. 2010;107:16325&#x2013;30. doi: 10.1073/pnas.1003459107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1003459107</ArticleId><ArticleId IdType="pmc">PMC2941282</ArticleId><ArticleId IdType="pubmed">20736350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y-F, Gendron TF, Zhang Y-J, Lin W-L, D&#x2019;Alton S, Sheng H, et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci. 2010;30:10851&#x2013;9. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo X, Zhou J, Li Y, Wu K, Chen Z, Luo Z, et al. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS. Nat Struct Mol Biol. 2021;28:132&#x2013;42. doi: 10.1038/s41594-020-00537-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-00537-7</ArticleId><ArticleId IdType="pubmed">33398173</ArticleId></ArticleIdList></Reference><Reference><Citation>Altman T, Ionescu A, Ibraheem A, Priesmann D, Gradus-Pery T, Farberov L, et al. Axonal TDP-43 condensates drive neuromuscular junction disruption through inhibition of local synthesis of nuclear encoded mitochondrial proteins. Nat Commun. 2021;12:6914. doi: 10.1038/s41467-021-27221-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27221-8</ArticleId><ArticleId IdType="pmc">PMC8617040</ArticleId><ArticleId IdType="pubmed">34824257</ArticleId></ArticleIdList></Reference><Reference><Citation>Stribl C, Samara A, Tr&#xfc;mbach D, Peis R, Neumann M, Fuchs H, et al. Mitochondrial dysfunction and decrease in body weight of a transgenic knock-in mouse model for TDP-43. J Biol Chem. 2014;289:10769&#x2013;84. doi: 10.1074/jbc.M113.515940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.515940</ArticleId><ArticleId IdType="pmc">PMC4036193</ArticleId><ArticleId IdType="pubmed">24515116</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Cortez C, Gan W-B, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413&#x2013;24. doi: 10.1093/hmg/ddt528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstreken P, Ly CV, Venken KJT, Koh T-W, Zhou Y, Bellen HJ. Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron. 2005;47:365&#x2013;78. doi: 10.1016/j.neuron.2005.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.06.018</ArticleId><ArticleId IdType="pubmed">16055061</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CW, Peng HB. The function of mitochondria in presynaptic development at the neuromuscular junction. Mol Biol Cell. 2008;19:150&#x2013;8. doi: 10.1091/mbc.e07-05-0515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e07-05-0515</ArticleId><ArticleId IdType="pmc">PMC2174173</ArticleId><ArticleId IdType="pubmed">17942598</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin KR, Godena VK, Hewitt VL, Whitworth AJ. Axonal transport defects are a common phenotype in Drosophila models of ALS. Hum Mol Genet. 2016;25:2378&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5181624</ArticleId><ArticleId IdType="pubmed">27056981</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;8. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Yilmaz R, M&#xfc;ller K, Grehl T, Petri S, Meyer T, et al. Hot-spot KIF5A mutations cause familial ALS. Brain. 2018;141:688&#x2013;97. doi: 10.1093/brain/awx370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C-H, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, et al. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalonde R, Strazielle C. Neurobehavioral characteristics of mice with modified intermediate filament genes. Rev Neurosci. 2003;14:369&#x2013;386. doi: 10.1515/REVNEURO.2003.14.4.369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/REVNEURO.2003.14.4.369</ArticleId><ArticleId IdType="pubmed">14640321</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelidou M, Zographos SE, Lederer CW, Kyriakides T, Pfaffl MW, Santama N. Differential expression of molecular motors in the motor cortex of sporadic ALS. Neurobiol Dis. 2007;26:577&#x2013;89. doi: 10.1016/j.nbd.2007.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.02.005</ArticleId><ArticleId IdType="pubmed">17418584</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Montiel MJ, Chaineau M, Durcan TM. The neglected genes of ALS: cytoskeletal dynamics impact synaptic degeneration in ALS. Front Cell Neurosci. 2020;14:1&#x2013;10. doi: 10.3389/fncel.2020.594975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.594975</ArticleId><ArticleId IdType="pmc">PMC7691654</ArticleId><ArticleId IdType="pubmed">33281562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotem N, Magen I, Ionescu A, Gershoni-Emek N, Altman T, Costa CJ, et al. ALS along the axons: expression of coding and noncoding RNA differs in axons of ALS models. Sci Rep. 2017;7:44500. doi: 10.1038/srep44500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44500</ArticleId><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>Briese M, Saal-Bauernschubert L, L&#xfc;ningschr&#xf6;r P, Moradi M, Dombert B, Surrey V, et al. Loss of Tdp-43 disrupts the axonal transcriptome of motoneurons accompanied by impaired axonal translation and mitochondria function. Acta Neuropathol Commun. 2020;8:116. doi: 10.1186/s40478-020-00987-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00987-6</ArticleId><ArticleId IdType="pmc">PMC7379803</ArticleId><ArticleId IdType="pubmed">32709255</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan RK, Mangelsdorf M, Panwar A, Butler TJ, Noakes PG, Wallace RH. Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain. Amyotroph Lateral Scler Front Degener. 2013;14:252&#x2013;60. doi: 10.3109/21678421.2012.734520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.734520</ArticleId><ArticleId IdType="pubmed">23134510</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder P, Chu J-F, Chatterjee B, Swamy KBS, Shen C-KJ. Co-regulation of mRNA translation by TDP-43 and Fragile X syndrome protein FMRP. Acta Neuropathol. 2016;132:721&#x2013;38. doi: 10.1007/s00401-016-1603-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1603-8</ArticleId><ArticleId IdType="pmc">PMC5073124</ArticleId><ArticleId IdType="pubmed">27518042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiguro A, Kimura N, Watanabe Y, Watanabe S, Ishihama A. TDP-43 binds and transports G-quadruplex-containing mRNAs into neurites for local translation. Genes Cells. 2016;21:466&#x2013;81. doi: 10.1111/gtc.12352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12352</ArticleId><ArticleId IdType="pubmed">26915990</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YQ, Bailey AM, Matthies HJG, Renden RB, Smith MA, Speese SD, et al. Drosophila Fragile X-related gene regulates the MAP1B homolog Futsch to control synaptic structure and function. Cell. 2001;107:591&#x2013;603. doi: 10.1016/S0092-8674(01)00589-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00589-X</ArticleId><ArticleId IdType="pubmed">11733059</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Leahy SN, Rushton EM, Broadie K. RNA-binding FMRP and staufen sequentially regulate the coracle scaffold to control synaptic glutamate receptor and bouton development. Development. 2022;149:dev200045. doi: 10.1242/dev.200045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.200045</ArticleId><ArticleId IdType="pmc">PMC9148565</ArticleId><ArticleId IdType="pubmed">35394012</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S, Jinno J, Abdelhamid RF, Jin Y, Shibata M, Watanabe S, et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol. 2020;140:695&#x2013;713. doi: 10.1007/s00401-020-02205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakata T, Terada S, Hirokawa N. Visualization of the dynamics of synaptic vesicle and plasma membrane proteins in living axons. J Cell Biol. 1998;140:659&#x2013;74. doi: 10.1083/jcb.140.3.659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.140.3.659</ArticleId><ArticleId IdType="pmc">PMC2140163</ArticleId><ArticleId IdType="pubmed">9456325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai RG, Vardinon-Friedman H, Cases-Langhoff C, Becker B, Gundelfinger ED, Ziv NE, et al. Assembling the presynaptic active zone: a characterization of an active zone precursor vesicle. Neuron. 2001;29:131&#x2013;43. doi: 10.1016/S0896-6273(01)00185-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00185-4</ArticleId><ArticleId IdType="pubmed">11182086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfman FC, Escudero CA, Weis J, Kruttgen A. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol. 2007;67:1183&#x2013;203. doi: 10.1002/dneu.20513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20513</ArticleId><ArticleId IdType="pubmed">17514710</ArticleId></ArticleIdList></Reference><Reference><Citation>Marqu&#xe9;s G, Bao H, Haerry TE, Shimell MJ, Duchek P, Zhang B, et al. The Drosophila BMP type II receptor wishful thinking regulates neuromuscular synapse morphology and function. Neuron. 2002;33:529&#x2013;43. doi: 10.1016/S0896-6273(02)00595-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00595-0</ArticleId><ArticleId IdType="pubmed">11856528</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe BD, Marqu&#xe9;s G, Haghighi AP, Fetter RD, Crotty ML, Haerry TE, et al. The BMP homolog gbb provides a retrograde signal that regulates synaptic growth at the Drosophila neuromuscular junction. Neuron. 2003;39:241&#x2013;54. doi: 10.1016/S0896-6273(03)00426-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00426-4</ArticleId><ArticleId IdType="pubmed">12873382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura M, Ito H, Wate R, Nakano S, Hirano A, Kusaka H. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model. Acta Neuropathol. 2008;115:327&#x2013;34. doi: 10.1007/s00401-007-0337-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0337-z</ArticleId><ArticleId IdType="pubmed">18210139</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philos Trans R Soc Lond. 1850;140:423&#x2013;9.</Citation></Reference><Reference><Citation>Lubi&#x144;ska L. Early course of wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res. 1977;130:47&#x2013;63. doi: 10.1016/0006-8993(77)90841-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(77)90841-1</ArticleId><ArticleId IdType="pubmed">884520</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdts J, Summers DW, Sasaki Y, DiAntonio A, Milbrandt J. Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J Neurosci. 2013;33:13569&#x2013;80. doi: 10.1523/JNEUROSCI.1197-13.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1197-13.2013</ArticleId><ArticleId IdType="pmc">PMC3742939</ArticleId><ArticleId IdType="pubmed">23946415</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdts J, Brace EJ, Sasaki Y, DiAntonio A, Milbrandt J. SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science. 2015;348:453&#x2013;7. doi: 10.1126/science.1258366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1258366</ArticleId><ArticleId IdType="pmc">PMC4513950</ArticleId><ArticleId IdType="pubmed">25908823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Orsomando G, Nascimento-Ferreira I, Coleman MP. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons. Cell Rep. 2015;10:1974&#x2013;81. doi: 10.1016/j.celrep.2015.02.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.02.060</ArticleId><ArticleId IdType="pmc">PMC4386025</ArticleId><ArticleId IdType="pubmed">25818290</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Ribchester RR, Coleman MP. Sarm1 deletion, but not WldS, confers lifelong rescue in a mouse model of severe axonopathy. Cell Rep. 2017;21:10&#x2013;6. doi: 10.1016/j.celrep.2017.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.027</ArticleId><ArticleId IdType="pmc">PMC5640801</ArticleId><ArticleId IdType="pubmed">28978465</ArticleId></ArticleIdList></Reference><Reference><Citation>Loreto A, Di Stefano M, Gering M, Conforti L. Wallerian degeneration is executed by an NMN-SARM1-dependent late Ca2+ influx but only modestly influenced by mitochondria. Cell Rep. 2015;13:2539&#x2013;52. doi: 10.1016/j.celrep.2015.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.11.032</ArticleId><ArticleId IdType="pubmed">26686637</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, et al. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 2012;337:481&#x2013;4. doi: 10.1126/science.1223899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1223899</ArticleId><ArticleId IdType="pmc">PMC5225956</ArticleId><ArticleId IdType="pubmed">22678360</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I, Ratti A, Gellera C, Lin K, Tiloca C, Moskvina V, et al. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23:2220&#x2013;31. doi: 10.1093/hmg/ddt587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt587</ArticleId><ArticleId IdType="pmc">PMC3959809</ArticleId><ArticleId IdType="pubmed">24256812</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilley J, Jackson O, Pipis M, Estiar MA, Al-Chalabi A, Danzi MC, et al. Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife. 2021;10:e70905. doi: 10.7554/eLife.70905.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70905</ArticleId><ArticleId IdType="pmc">PMC8735862</ArticleId><ArticleId IdType="pubmed">34796871</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom AJ, Mao X, Strickland A, Sasaki Y, Milbrandt J, DiAntonio A. Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients. Mol Neurodegener. 2022;17:1. doi: 10.1186/s13024-021-00511-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00511-x</ArticleId><ArticleId IdType="pmc">PMC8739729</ArticleId><ArticleId IdType="pubmed">34991663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajadi A. Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr Biol. 2004;14:326&#x2013;30. doi: 10.1016/j.cub.2004.01.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2004.01.053</ArticleId><ArticleId IdType="pubmed">14972684</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J, Grutzendler J, Duff K, Gan W-B. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci. 2004;7:1181&#x2013;3. doi: 10.1038/nn1335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1335</ArticleId><ArticleId IdType="pubmed">15475950</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvin JE, Uryu K, Lee VMY, Trojanowski JQ. Axon pathology in Parkinson&#x2019;s disease and Lewy body dementia hippocampus contains &#x3b1;-, &#x3b2;-, and &#x3b3;-synuclein. Proc Natl Acad Sci U S A. 1999;96:13450&#x2013;5. doi: 10.1073/pnas.96.23.13450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.23.13450</ArticleId><ArticleId IdType="pmc">PMC23968</ArticleId><ArticleId IdType="pubmed">10557341</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer&#x2019;s disease. Science. 2005;307:1282&#x2013;8. doi: 10.1126/science.1105681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1105681</ArticleId><ArticleId IdType="pubmed">15731448</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li S-H, Yu Z-X, Shelbourne P, Li X-J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington&#x2019;s disease mice. J Neurosci. 2001;21:8473&#x2013;81. doi: 10.1523/JNEUROSCI.21-21-08473.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-21-08473.2001</ArticleId><ArticleId IdType="pmc">PMC6762783</ArticleId><ArticleId IdType="pubmed">11606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S, Iwata M. Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2007;66:10&#x2013;6. doi: 10.1097/nen.0b013e31802c396b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31802c396b</ArticleId><ArticleId IdType="pubmed">17204932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem. 2002;80:616&#x2013;25. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol. 1999;46:787&#x2013;90. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K, Mepham J, Volkening K, Welch I, Hill T, Strong MJ. Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL&#x2013;/&#x2013; mice: support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res. 2009;1296:176&#x2013;86. doi: 10.1016/j.brainres.2009.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.07.023</ArticleId><ArticleId IdType="pubmed">19619516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Takeuchi S, Saito A, Ding W, Bamba H, Matsuura H, et al. Axonal ligation induces transient redistribution of TDP-43 in brainstem motor neurons. Neuroscience. 2009;164:1565&#x2013;78. doi: 10.1016/j.neuroscience.2009.09.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.09.050</ArticleId><ArticleId IdType="pubmed">19782731</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, Strong MJ. Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res. 2009;1249:202&#x2013;11. doi: 10.1016/j.brainres.2008.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.10.021</ArticleId><ArticleId IdType="pubmed">19046946</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Audet JN, Phaneuf D, Kriz J, Julien JP. Abnormal regenerative responses and impaired axonal outgrowth after nerve crush in TDP-43 transgenic mouse models of amyotrophic lateral sclerosis. J Neurosci. 2012;32:18186&#x2013;95. doi: 10.1523/JNEUROSCI.2267-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2267-12.2012</ArticleId><ArticleId IdType="pmc">PMC6621743</ArticleId><ArticleId IdType="pubmed">23238732</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe9;ri&#xe8;pe J, Fossouo L, Parker JA. Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons. Nat Commun. 2015;6:7319. doi: 10.1038/ncomms8319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8319</ArticleId><ArticleId IdType="pubmed">26059317</ArticleId></ArticleIdList></Reference><Reference><Citation>Velde C, Vande, Garcia ML, Yin X, Trapp BD, Cleveland DW. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease. NeuroMolecular Med. 2004;5:193&#x2013;204. doi: 10.1385/NMM:5:3:193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/NMM:5:3:193</ArticleId><ArticleId IdType="pubmed">15626820</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters OM, Lewis EA, Osterloh JM, Weiss A, Salameh JS, Metterville J, et al. Loss of Sarm1 does not suppress motor neuron degeneration in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2018;27:3761&#x2013;71. doi: 10.1093/hmg/ddy260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy260</ArticleId><ArticleId IdType="pmc">PMC6196650</ArticleId><ArticleId IdType="pubmed">30010873</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques RF, Engler JB, K&#xfc;chler K, Jones RA, Lingner T, Salinas G, et al. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models. Hum Mol Genet. 2020;29:2647&#x2013;61. doi: 10.1093/hmg/ddaa140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa140</ArticleId><ArticleId IdType="pmc">PMC7530531</ArticleId><ArticleId IdType="pubmed">32686835</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22:167&#x2013;79. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180&#x2013;90. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Babetto E, Beirowski B, Russler EV, Milbrandt J, DiAntonio A. The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction. Cell Rep. 2013;3:1422&#x2013;9. doi: 10.1016/j.celrep.2013.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.04.013</ArticleId><ArticleId IdType="pmc">PMC3671584</ArticleId><ArticleId IdType="pubmed">23665224</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom AJ, Miller BR, Sanes JR, DiAntonio A. The requirement for Phr1 in CNS axon tract formation reveals the corticostriatal boundary as a choice point for cortical axons. Genes Dev. 2007;21:2593&#x2013;606. doi: 10.1101/gad.1592107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1592107</ArticleId><ArticleId IdType="pmc">PMC2000324</ArticleId><ArticleId IdType="pubmed">17901218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewcock JW, Genoud N, Lettieri K, Pfaff SL. The ubiquitin ligase Phr1 regulates axon outgrowth through modulation of microtubule dynamics. Neuron. 2007;56:604&#x2013;20. doi: 10.1016/j.neuron.2007.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.09.009</ArticleId><ArticleId IdType="pubmed">18031680</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess RW, Peterson KA, Johnson MJ, Roix JJ, Welsh IC, O&#x2019;Brien TP. Evidence for a conserved function in synapse formation reveals Phr1 as a candidate gene for respiratory failure in newborn mice. Mol Cell Biol. 2004;24:1096&#x2013;105. doi: 10.1128/MCB.24.3.1096-1105.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.3.1096-1105.2004</ArticleId><ArticleId IdType="pmc">PMC321423</ArticleId><ArticleId IdType="pubmed">14729956</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JE, Miller BR, Babetto E, Cho Y, Sasaki Y, Qayum S, et al. SCG10 is a JNK target in the axonal degeneration pathway. Proc Natl Acad Sci U S A. 2012;109:e3696&#x2013;705. doi: 10.1073/pnas.1216204109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1216204109</ArticleId><ArticleId IdType="pmc">PMC3535671</ArticleId><ArticleId IdType="pubmed">23188802</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JE, Geisler S, DiAntonio A. Dynamic regulation of SCG10 in regenerating axons after injury. Exp Neurol. 2014;252:1&#x2013;11. doi: 10.1016/j.expneurol.2013.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.11.007</ArticleId><ArticleId IdType="pmc">PMC3947015</ArticleId><ArticleId IdType="pubmed">24246279</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf ER, Heerssen HM, Wright CM, Davis GW, DiAntonio A. Stathmin is required for stability of the Drosophila neuromuscular junction. J Neurosci. 2011;31:15026&#x2013;34. doi: 10.1523/JNEUROSCI.2024-11.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2024-11.2011</ArticleId><ArticleId IdType="pmc">PMC3207242</ArticleId><ArticleId IdType="pubmed">22016536</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan JE, Lytle NK, Zuniga A, Goldstein LSB. The microtubule regulatory protein stathmin is required to maintain the integrity of axonal microtubules in Drosophila. PLoS ONE. 2013;8:e68324. doi: 10.1371/journal.pone.0068324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068324</ArticleId><ArticleId IdType="pmc">PMC3694009</ArticleId><ArticleId IdType="pubmed">23840848</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerra San Juan I, Nash LA, Smith KS, Leyton-Jaimes MF, Qian M, Klim JR, et al. Loss of mouse Stmn2 function causes motor neuropathy. Neuron. 2022;110:1671&#x2013;88.e6. doi: 10.1016/j.neuron.2022.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.02.011</ArticleId><ArticleId IdType="pmc">PMC9119928</ArticleId><ArticleId IdType="pubmed">35294901</ArticleId></ArticleIdList></Reference><Reference><Citation>Liedtke W, Leman EE, Fyffe REW, Raine CS, Schubart UK. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol. 2002;160:469&#x2013;80. doi: 10.1016/S0002-9440(10)64866-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64866-3</ArticleId><ArticleId IdType="pmc">PMC1850667</ArticleId><ArticleId IdType="pubmed">11839567</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem. 2009;284:20329&#x2013;39. doi: 10.1074/jbc.M109.010264.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.010264</ArticleId><ArticleId IdType="pmc">PMC2740458</ArticleId><ArticleId IdType="pubmed">19465477</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, Zago P, D&#x2019;Ambrogio A, Xu YF, Petrucelli L, Buratti E, et al. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci. 2008;121:3778&#x2013;85. doi: 10.1242/jcs.038950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.038950</ArticleId><ArticleId IdType="pubmed">18957508</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, Lorenzini I, Chou CC, Torvund M, Rogers RS, Starr A, et al. Post-transcriptional inhibition of Hsc70-4/HSPA8 expression leads to synaptic vesicle cycling defects in multiple models of ALS. Cell Rep. 2017;21:110&#x2013;25. doi: 10.1016/j.celrep.2017.09.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.09.028</ArticleId><ArticleId IdType="pmc">PMC5679478</ArticleId><ArticleId IdType="pubmed">28978466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedersha N, Chen S, Gilks N, Li W, Miller IJ, Stahl J, et al. Evidence that ternary complex (eIF2-GTP-tRNAiMet)&#x2013;deficient preinitiation complexes are core constituents of mammalian stress granules. Mol Biol Cell. 2002;13:195&#x2013;210. doi: 10.1091/mbc.01-05-0221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.01-05-0221</ArticleId><ArticleId IdType="pmc">PMC65082</ArticleId><ArticleId IdType="pubmed">11809833</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli L, Crugnola V, Lamperti C, Silani V, Di Mauro S, Bresolin N, et al. Ultrastructural mitochondrial abnormalities in patients with sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68:1612&#x2013;3. doi: 10.1001/archneur.68.12.1612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.68.12.1612</ArticleId><ArticleId IdType="pubmed">22159065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MJ, Suh Y-L. Ultrastructural changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol. 2002;26:3&#x2013;7. doi: 10.1080/01913120252934260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Afifi AK, Aleu FP, Goodgold J, MacKay B. Ultrastructure of atrophic muscle in amyotrophic lateral sclerosis. Neurology. 1966;16:475&#x2013;5. doi: 10.1212/WNL.16.5.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.16.5.475</ArticleId><ArticleId IdType="pubmed">5949060</ArticleId></ArticleIdList></Reference><Reference><Citation>Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, et al. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:849&#x2013;54. doi: 10.1001/archneurol.2010.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.128</ArticleId><ArticleId IdType="pubmed">20625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Zoll J, Ponsot E, N&#x2019;Guessan B, Tranchant C, Loeffler J-P, et al. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol. 2006;198:25&#x2013;30. doi: 10.1016/j.expneurol.2005.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.07.020</ArticleId><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, Winkler K, Kirches E, Kunz D, B&#xfc;chner M, Feistner H, et al. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:133&#x2013;9. doi: 10.1016/S0022-510X(99)00236-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00236-1</ArticleId><ArticleId IdType="pubmed">10540022</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci. 1998;156:65&#x2013;72. doi: 10.1016/S0022-510X(98)00008-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(98)00008-2</ArticleId><ArticleId IdType="pubmed">9559989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C, Serafini M, Prelle A, Magni P, Dozio E, Ruscica M, et al. Impaired expression of insulin-like growth factor&#x2010;1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve. 2012;45:200&#x2013;8. doi: 10.1002/mus.22288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22288</ArticleId><ArticleId IdType="pmc">PMC3306791</ArticleId><ArticleId IdType="pubmed">22246875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T. Expression of glial cell line-derived growth factor mRNA in the spinal cord and muscle in amyotrophic lateral sclerosis. Neurosci Lett. 1996;204:117&#x2013;20. doi: 10.1016/0304-3940(96)12342-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12342-9</ArticleId><ArticleId IdType="pubmed">8929992</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, Bauch&#xe9; S, Gonzalez de Aguilar JL, Brochier G, Mandjee N, Tanguy M-L, et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol. 2015;2:362&#x2013;72. doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Koistinen H, Prinjha R, Soden P, Harper A, Banner SJ, Pradat P-F, et al. Elevated levels of amyloid precursor protein in muscle of patients with amyotrophic lateral sclerosis and a mouse model of the disease. Muscle Nerve. 2006;34:444&#x2013;50. doi: 10.1002/mus.20612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20612</ArticleId><ArticleId IdType="pubmed">16856153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic N, Gonzalez de Aguilar J-L, Pradat P-F, Dupuis L, Echaniz-Laguna A, Muller A, et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol. 2005;57:553&#x2013;6. doi: 10.1002/ana.20420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20420</ArticleId><ArticleId IdType="pubmed">15786457</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agostino C, Nogalska A, Engel WK, Askanas V. In sporadic inclusion body myositis muscle fibres TDP-43-positive inclusions are less frequent and robust than p62 inclusions, and are not associated with paired helical filaments. Neuropathol Appl Neurobiol. 2011;37:315&#x2013;20. doi: 10.1111/j.1365-2990.2010.01108.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2010.01108.x</ArticleId><ArticleId IdType="pubmed">20626631</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008;79:1186&#x2013;9. doi: 10.1136/jnnp.2007.131334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2007.131334</ArticleId><ArticleId IdType="pmc">PMC2586594</ArticleId><ArticleId IdType="pubmed">18796596</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M-L, Bourefis A-R, Kabashi E. Diagnostic challenge and neuromuscular junction contribution to ALS pathogenesis. Front Neurol. 2019;10:1&#x2013;8. doi: 10.3389/fneur.2019.00068.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00068</ArticleId><ArticleId IdType="pmc">PMC6372519</ArticleId><ArticleId IdType="pubmed">30787905</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun. 2019;7:165. doi: 10.1186/s40478-019-0824-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pmc">PMC6816170</ArticleId><ArticleId IdType="pubmed">31661037</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2018;6:28. doi: 10.1186/s40478-018-0528-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pmc">PMC5899326</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez Lain A, Millecamps S, Dubourg O, Salachas F, Bruneteau G, Lacomblez L, et al. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patient. J Neurol Neurosurg Psychiatry. 2011;82:1414&#x2013;6. doi: 10.1136/jnnp.2010.208868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.208868</ArticleId><ArticleId IdType="pubmed">20562395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler TO, Wheeler JR, Nguyen ED, Hughes MP, Britson KA, Lester E, et al. TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature. 2018;563:508&#x2013;13. doi: 10.1038/s41586-018-0665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0665-2</ArticleId><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Militello G, Hosen MR, Ponomareva Y, Gellert P, Weirick T, John D, et al. A novel long non-coding RNA myolinc regulates myogenesis through TDP-43 and Filip1. J Mol Cell Biol. 2018;10:102&#x2013;17. doi: 10.1093/jmcb/mjy025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjy025</ArticleId><ArticleId IdType="pmc">PMC7191624</ArticleId><ArticleId IdType="pubmed">29618024</ArticleId></ArticleIdList></Reference><Reference><Citation>Tawara N, Yamashita S, Kawakami K, Kurashige T, Zhang Z, Tasaki M, et al. Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions. Exp Neurol. 2018;309:169&#x2013;80. doi: 10.1016/j.expneurol.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.08.006</ArticleId><ArticleId IdType="pubmed">30130494</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid B, Hruscha A, Hogl S, Banzhaf-Strathmann J, Strecker K, van der Zee J, et al. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A. 2013;110:4986&#x2013;91. doi: 10.1073/pnas.1218311110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1218311110</ArticleId><ArticleId IdType="pmc">PMC3612625</ArticleId><ArticleId IdType="pubmed">23457265</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaper DC, Adachi Y, Lazarou L, Greenstein M, Simoes FA, Di Domenico A, et al. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet. 2013;22:3883&#x2013;93. doi: 10.1093/hmg/ddt243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt243</ArticleId><ArticleId IdType="pmc">PMC3766182</ArticleId><ArticleId IdType="pubmed">23727833</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramozza A, Marchese V, Papa V, Salaroli R, Sorar&#xf9; G, Angelini C, et al. Skeletal muscle satellite cells in amyotrophic lateral sclerosis. Ultrastruct Pathol. 2014;38:295&#x2013;302. doi: 10.3109/01913123.2014.937842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2014.937842</ArticleId><ArticleId IdType="pubmed">25079897</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F, Barani A, Wanschitz J, Dubourg O, Lomb&#xe8;s A, Bigot A, et al. Abnormalities of satellite cells function in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:264&#x2013;71. doi: 10.3109/17482968.2011.566618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.566618</ArticleId><ArticleId IdType="pubmed">21473708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohsaka H, Takasu E, Nose A. In vivo induction of postsynaptic molecular assembly by the cell adhesion molecule Fasciclin2. J Cell Biol. 2007;179:1289&#x2013;300. doi: 10.1083/jcb.200705154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200705154</ArticleId><ArticleId IdType="pmc">PMC2140041</ArticleId><ArticleId IdType="pubmed">18070911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zito K, Fetter RD, Goodman CS, Isacoff EY. Synaptic clustering of Fasciclin II and Shaker: essential targeting sequences and role of Dlg. Neuron. 1997;19:1007&#x2013;16. doi: 10.1016/S0896-6273(00)80393-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80393-1</ArticleId><ArticleId IdType="pubmed">9390515</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas U, Kim E, Kuhlendahl S, Koh YH, Gundelfinger ED, Sheng M, et al. Synaptic clustering of the cell adhesion molecule fasciclin II by discs-large and its role in the regulation of presynaptic structure. Neuron. 1997;19:787&#x2013;99. doi: 10.1016/S0896-6273(00)80961-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80961-7</ArticleId><ArticleId IdType="pmc">PMC4658217</ArticleId><ArticleId IdType="pubmed">9354326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch EM, Robertson S, FitzGibbons C, Reilly M, Switalski C, Eckardt A, et al. Transcriptome analysis using patient iPSC-derived skeletal myocytes: Bet1L as a new molecule possibly linked to neuromuscular junction degeneration in ALS. Exp Neurol. 2021;345:113815. doi: 10.1016/j.expneurol.2021.113815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113815</ArticleId><ArticleId IdType="pmc">PMC8429236</ArticleId><ArticleId IdType="pubmed">34310943</ArticleId></ArticleIdList></Reference><Reference><Citation>King IN, Yartseva V, Salas D, Kumar A, Heidersbach A, Ando DM, et al. The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex. J Biol Chem. 2014;289:14263&#x2013;71. doi: 10.1074/jbc.M114.561902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.561902</ArticleId><ArticleId IdType="pmc">PMC4022891</ArticleId><ArticleId IdType="pubmed">24719334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38:228&#x2013;33. doi: 10.1038/ng1725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1725</ArticleId><ArticleId IdType="pmc">PMC2538576</ArticleId><ArticleId IdType="pubmed">16380711</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivey KN, Muth A, Arnold J, King FW, Yeh R-F, Fish JE, et al. MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell. 2008;2:219&#x2013;29. doi: 10.1016/j.stem.2008.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2008.01.016</ArticleId><ArticleId IdType="pmc">PMC2293325</ArticleId><ArticleId IdType="pubmed">18371447</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon DJ, Madison JM, Conery AL, Thompson-Peer KL, Soskis M, Ruvkun GB, et al. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell. 2008;133:903&#x2013;15. doi: 10.1016/j.cell.2008.04.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.04.035</ArticleId><ArticleId IdType="pmc">PMC2553566</ArticleId><ArticleId IdType="pubmed">18510933</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;54. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Peter RS, Rosenbohm A, Koenig W, Dupuis L, Rothenbacher D, et al. Association of insulin-like growth factor 1 concentrations with risk for and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Sci Rep. 2020;10:736. doi: 10.1038/s41598-020-57744-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57744-x</ArticleId><ArticleId IdType="pmc">PMC6971302</ArticleId><ArticleId IdType="pubmed">31959864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, Simonet T, Bauch&#xe9; S, Mandjee N, Malfatti E, Girard E, et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain. 2013;136:2359&#x2013;68. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Pietro L, Baranzini M, Berardinelli MG, Lattanzi W, Monforte M, Tasca G, et al. Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients. Sci Rep. 2017;7:9538. doi: 10.1038/s41598-017-10161-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-10161-z</ArticleId><ArticleId IdType="pmc">PMC5573384</ArticleId><ArticleId IdType="pubmed">28842714</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xe4;chter N, Storch A, Hermann A, Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms. Amyotroph Lateral Scler Front Degener. 2015;16:431&#x2013;41. doi: 10.3109/21678421.2015.1055275.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1055275</ArticleId><ArticleId IdType="pubmed">26174443</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimon R, Ionescu A, Bonnie A, Sweetat S, Wald-Altman S, Inbar S, et al. miR126-5p downregulation facilitates axon degeneration and NMJ disruption via a non&#x2013;cell-autonomous mechanism in ALS. J Neurosci. 2018;38:5478&#x2013;94. doi: 10.1523/JNEUROSCI.3037-17.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3037-17.2018</ArticleId><ArticleId IdType="pmc">PMC6001038</ArticleId><ArticleId IdType="pubmed">29773756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T, Kawakami E, Endo K, Misawa H, Watabe K. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE. 2017;12:e0179375. doi: 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29:824&#x2013;8. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas F, Cortes N, Abarzua S, Dyrda A, van Zundert B. Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress. Front Cell Neurosci. 2014;8:24. doi: 10.3389/fncel.2014.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00024</ArticleId><ArticleId IdType="pmc">PMC3916762</ArticleId><ArticleId IdType="pubmed">24570655</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang B, Bi F, Yan LH, Tong J, Huang J, et al. Profiling the genes affected by pathogenic TDP-43 in astrocytes. J Neurochem. 2014;129:932&#x2013;9. doi: 10.1111/jnc.12660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12660</ArticleId><ArticleId IdType="pmc">PMC4066372</ArticleId><ArticleId IdType="pubmed">24447103</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca TJ, Mariani A, Watkins LR, Link CD. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol Dis. 2019;132:104514. doi: 10.1016/j.nbd.2019.104514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104514</ArticleId><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia. 2020;68:407&#x2013;21. doi: 10.1002/glia.23728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23728</ArticleId><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke YD, van Hummel A, Stevens CH, Gladbach A, Ippati S, Bi M, et al. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol. 2015;130:661&#x2013;78. doi: 10.1007/s00401-015-1486-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1486-0</ArticleId><ArticleId IdType="pubmed">26437864</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Gautam M, Kocak N, Xie EF, Mao Q, Bigio EH, et al. MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology. J Neuroinflamm. 2019;16:196. doi: 10.1186/s12974-019-1589-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1589-y</ArticleId><ArticleId IdType="pmc">PMC6822373</ArticleId><ArticleId IdType="pubmed">31666087</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JD, Levin SC, Willis EF, Li R, Woodruff TM, Noakes PG. Complement components are upregulated and correlate with disease progression in the TDP-43 Q331K mouse model of amyotrophic lateral sclerosis. J Neuroinflamm. 2018;15:171. doi: 10.1186/s12974-018-1217-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1217-2</ArticleId><ArticleId IdType="pmc">PMC5984816</ArticleId><ArticleId IdType="pubmed">29859100</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y-F, Zhang Y-J, Lin W-L, Cao X, Stetler C, Dickson DW, et al. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice. Mol Neurodegener. 2011;6:73. doi: 10.1186/1750-1326-6-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-6-73</ArticleId><ArticleId IdType="pmc">PMC3216869</ArticleId><ArticleId IdType="pubmed">22029574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim S, Kang HY, Lim HR, Kwon Y, Jo M, et al. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J Neuroinflamm. 2020;17:299. doi: 10.1186/s12974-020-01963-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01963-6</ArticleId><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng AYT, Agrawal I, Ho WY, Yen YC, Pinter AJ, Liu J, et al. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. Proc Natl Acad Sci U S A. 2020;117:29101&#x2013;12. doi: 10.1073/pnas.2007806117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2007806117</ArticleId><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Ho WY, Lim K, Feng J, Tucker-Kellogg G, Nave K-A, et al. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc Natl Acad Sci U S A. 2018;115:e10941&#x2013;50. doi: 10.1073/pnas.1809821115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809821115</ArticleId><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho WY, Chang J-C, Lim K, Cazenave-Gassiot A, Nguyen AT, Foo JC, et al. TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination. J Cell Biol. 2021;220:e201910213. doi: 10.1083/jcb.201910213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201910213</ArticleId><ArticleId IdType="pmc">PMC8348376</ArticleId><ArticleId IdType="pubmed">34347016</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo D, Ling JP, Molina-Castro GC, Langseth AJ, Waisman A, Nave K-A, et al. Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43. Elife. 2022;11:e75230. doi: 10.7554/eLife.75230.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.75230</ArticleId><ArticleId IdType="pmc">PMC8970587</ArticleId><ArticleId IdType="pubmed">35311646</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995;38:73&#x2013;84. doi: 10.1002/ana.410380114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380114</ArticleId><ArticleId IdType="pubmed">7611729</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, et al. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J. 2013;32:1917&#x2013;26. doi: 10.1038/emboj.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2013.122</ArticleId><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo MN, Francolini M. Glutamate at the vertebrate neuromuscular junction: from modulation to neurotransmission. Cells. 2019;8:996. doi: 10.3390/cells8090996.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8090996</ArticleId><ArticleId IdType="pmc">PMC6770210</ArticleId><ArticleId IdType="pubmed">31466388</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou HC, Yang RS, Fu WM. Potentiation of spontaneous acetylcholine release from motor nerve terminals by glutamate in Xenopus tadpoles. Neuroscience. 1996;75:325&#x2013;31. doi: 10.1016/0306-4522(96)00280-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(96)00280-1</ArticleId><ArticleId IdType="pubmed">8923545</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N, Gentile F, Cerri F, Gallia F, Podini P, Dina G, et al. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain. 2022;145:276&#x2013;84. doi: 10.1093/brain/awab285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab285</ArticleId><ArticleId IdType="pmc">PMC8967102</ArticleId><ArticleId IdType="pubmed">35076694</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrie WT, Lee GT, Curtis EM, Sparke J, Buller JR, Rossi ML. Changes in the myelinated axons of femoral nerve in amyotrophic lateral sclerosis. J Neural Transm Suppl. 1993;39:223&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">8360662</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang KJ, Agrawal I, Vainshtein A, Ho WY, Xin W, Tucker-Kellogg G, et al. TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells. Elife. 2021;10:e64456. doi: 10.7554/eLife.64456.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64456</ArticleId><ArticleId IdType="pmc">PMC7946431</ArticleId><ArticleId IdType="pubmed">33689679</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura-Shindo K, Sakai K, Shimizu A, Ishida C, Yamada M. Accumulation of phosphorylated TDP-43 in the cytoplasm of Schwann cells in a case of sporadic amyotrophic lateral sclerosis. Neuropathology. 2020;40:606&#x2013;10. doi: 10.1111/neup.12673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12673</ArticleId><ArticleId IdType="pubmed">32776323</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M. Electrodiagnosis of amyotrophic lateral sclerosis: a review of existing guidelines. J Clin Neurophysiol. 2020;37:294&#x2013;8. doi: 10.1097/WNP.0000000000000682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000682</ArticleId><ArticleId IdType="pubmed">33151660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanes JR, Lichtman JW. Development of the vertebrate neuromuscular junction. Annu Rev Neurosci. 1999;22:389&#x2013;442. doi: 10.1146/annurev.neuro.22.1.389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.22.1.389</ArticleId><ArticleId IdType="pubmed">10202544</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Ko C-P. The role of glial cells in the formation and maintenance of the neuromuscular junction. Ann N Y Acad Sci. 2008;1132:19&#x2013;28. doi: 10.1196/annals.1405.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1405.016</ArticleId><ArticleId IdType="pubmed">18567850</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy LV, Koirala S, Sugiura Y, Herrera AA, Ko C-P. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron. 2003;40:563&#x2013;80. doi: 10.1016/S0896-6273(03)00682-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(03)00682-2</ArticleId><ArticleId IdType="pubmed">14642280</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;lair E-L, Vall&#xe9;e J, Robitaille R. In vivo long-term synaptic plasticity of glial cells. J Physiol. 2010;588:1039&#x2013;56. doi: 10.1113/jphysiol.2009.178988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.178988</ArticleId><ArticleId IdType="pmc">PMC2852994</ArticleId><ArticleId IdType="pubmed">20142269</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y-J, Thompson WJ. Schwann cell processes guide regeneration of peripheral axons. Neuron. 1995;14:125&#x2013;32. doi: 10.1016/0896-6273(95)90246-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90246-5</ArticleId><ArticleId IdType="pubmed">7826630</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J Neurosci. 2004;24:10999&#x2013;1009. doi: 10.1523/JNEUROSCI.3934-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3934-04.2004</ArticleId><ArticleId IdType="pmc">PMC6730273</ArticleId><ArticleId IdType="pubmed">15590915</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y-J, Thompson WJ. Nerve sprouting in muscle is induced and guided by processes extended by schwann cells. Neuron. 1995;14:133&#x2013;41. doi: 10.1016/0896-6273(95)90247-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90247-3</ArticleId><ArticleId IdType="pubmed">7826631</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D, Tremblay E, Martineau &#xc9;, Julien J-P, Robitaille R. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J Neurosci. 2015;35:688&#x2013;706. doi: 10.1523/JNEUROSCI.1379-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605374</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco DI, Seburn KL, Pinter MJ. Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp Neurol. 2016;275:172&#x2013;81. doi: 10.1016/j.expneurol.2015.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.014</ArticleId><ArticleId IdType="pmc">PMC4768763</ArticleId><ArticleId IdType="pubmed">26416261</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau &#xc9;, Arbour D, Vall&#xe9;e J, Robitaille R. Properties of glial cell at the neuromuscular junction are incompatible with synaptic repair in the SOD1G37R ALS mouse model. J Neurosci. 2020;40:7759&#x2013;77. doi: 10.1523/JNEUROSCI.1748-18.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1748-18.2020</ArticleId><ArticleId IdType="pmc">PMC7531543</ArticleId><ArticleId IdType="pubmed">32859714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochon D, Rousse I, Robitaille R. Synapse&#x2013;glia interactions at the mammalian neuromuscular junction. J Neurosci. 2001;21:3819&#x2013;29. doi: 10.1523/JNEUROSCI.21-11-03819.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-11-03819.2001</ArticleId><ArticleId IdType="pmc">PMC6762689</ArticleId><ArticleId IdType="pubmed">11356870</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;29. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>